A Prospective, Single-Arm, Phase II, Multi-Center Study of Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer

A. C. Olson, J. H. Skiba, B. S. Gill,H. Wang, B. Davies,K. Holeva,D. D'Ambrosio,R. E. Wegner,D. E. Heron

International journal of radiation oncology, biology, physics（2021）

引用 0|浏览7

暂无评分

摘要

In one of the largest prospective series to date, prostate SBRT for low- and intermediate-risk prostate cancer is efficacious and well tolerated, with high rates of early biochemical control and low rates of clinically significant toxicity. Long-term outcomes will be reported with longer follow-up.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要